emoxypine succinate has been researched along with Chronic Illness in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Kuznetsov, NS; Kuznetsova, EB; Salina, EA | 1 |
| Abramenko, YV | 1 |
| Duma, SN | 1 |
| Chukanova, AS; Chukanova, EI; Mamayeva, KI | 1 |
| Berezhnaya, SV; Yakupov, EZ | 1 |
| Konoplya, AI; Laskov, VB; Shul'ginova, AA | 1 |
| Dolgushina, AI | 1 |
| Antipenko, EA | 1 |
| Deriabin, EI; Shumikhina, LA | 1 |
| Ellarian, LK; Kazarina, LN; Kuzin, VB; Tepaev, DV | 1 |
| Dev'iatkina, TO; Kovalenko, EH; Vazhnycha, OM | 1 |
5 trial(s) available for emoxypine succinate and Chronic Illness
| Article | Year |
|---|---|
[Possibilities of antioxidant therapy for asthenia and cognitive deficit in elderly patients with chronic brain ischemia].
Topics: Aged; Antioxidants; Asthenia; Brain Ischemia; Chronic Disease; Cognition Disorders; Female; Humans; Lipoproteins, LDL; Middle Aged; Picolines; Treatment Outcome | 2013 |
[The results of the study of the efficacy and safety of mexidol in patients with chronic cerebral ischemia].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antioxidants; Brain Ischemia; Chronic Disease; Dose-Response Relationship, Drug; Emotions; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neuroimaging; Picolines; Prospective Studies; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 2015 |
[Efficacy of emoxipine and mexidol in patients with chronic disorders of the digestive system and atherosclerosis of the abdominal aorta].
Topics: Abdominal Pain; Aged; Antioxidants; Aorta, Abdominal; Atherosclerosis; Chronic Disease; Digestive System Diseases; Female; Humans; Infusions, Intravenous; Lipid Peroxidation; Lipid Peroxides; Male; Picolines; Single-Blind Method; Treatment Outcome | 2011 |
[Adaptogenic effects of mexidol in chronic cerebral ischemia].
Topics: Adaptation, Physiological; Adult; Antioxidants; Brain Ischemia; Chronic Disease; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Picolines | 2012 |
[Influence of gel Metrogil Denta and curative toothpaste Mexidol Dent activ on indices of parodontal status and lipid peroxidation in patients with chronic generalized catarrhal gingivitis].
Topics: Adolescent; Adult; Chronic Disease; Drug Therapy, Combination; Female; Gels; Gingivitis; Humans; Lipid Peroxidation; Male; Metronidazole; Periodontal Index; Picolines; Toothpastes; Treatment Outcome | 2007 |
6 other study(ies) available for emoxypine succinate and Chronic Illness
| Article | Year |
|---|---|
[Efficacy of Mexidol in the correction of postcovid syndrome in patients with chronic cerebrovascular diseases].
Topics: Antioxidants; Asthenia; Cerebrovascular Disorders; Chronic Disease; COVID-19; Humans; Syndrome | 2023 |
[Results of the sequential use of Mexidol and Mexidol Forte 250 in patients with chronic cerebral ischemia].
Topics: Brain Ischemia; Chronic Disease; Humans; Neuroimaging; Picolines; Treatment Outcome | 2020 |
[The neuroprotective therapy of outpatient treatment of chronic cerebral ischemia].
Topics: Aged; Antioxidants; Bencyclane; Brain Ischemia; Chronic Disease; Drug Therapy, Combination; Escin; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Picolines; Treatment Outcome | 2015 |
[Immune and oxygen disturbances in patients with chronic cerebral ischemia and their correction].
Topics: Adult; Amino Acids; Antioxidants; Brain Ischemia; C-Reactive Protein; Chronic Disease; Complement C1 Inhibitor Protein; Complement Factor H; Complement System Proteins; Cytokines; Drug Therapy, Combination; Female; Heme; Humans; Hydrogen Peroxide; Immunoglobulins; Male; Malondialdehyde; Middle Aged; Nootropic Agents; Picolines; Piracetam | 2015 |
[Complex therapy of acute and exacerbated chronic nonspecific parotitis including mexidol and non-coherent infrared therapy].
Topics: Acute Disease; Adult; Aged; Antioxidants; Chronic Disease; Female; Follow-Up Studies; Humans; Infrared Rays; Injections, Intralymphatic; Male; Middle Aged; Parotitis; Picolines; Recurrence; Treatment Outcome | 2006 |
[The effect of mexidol on thymus cells in chronic hypokinesia].
Topics: Animals; Blood Cells; Bone Marrow; Bone Marrow Cells; Cell Movement; Chronic Disease; Hypokinesia; Male; Picolines; Psychotropic Drugs; Rats; Spleen; Thymus Gland; Time Factors | 1997 |